Liminatus Pharma Inc Cl A (LIMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||
| Net Income | -3,317 | -2,715 | 0 |
| Other Working Capital | 475 | 435 | 0 |
| Other Operating Activity | 1,531 | 1,176 | 0 |
| Operating Cash Flow | $-1,310 | $-1,104 | $N/A |
| Cash Flows From Investing Activities | |||
| Net Acquisitions | -2,300 | -1,500 | N/A |
| Investing Cash Flow | $-2,300 | $-1,500 | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 3,223 | 2,240 | N/A |
| Other Financing Activity | 0 | -36 | 0 |
| Financing Cash Flow | $3,223 | $2,204 | $N/A |
| Beginning Cash Position | 434 | 434 | N/A |
| End Cash Position | 47 | 34 | N/A |
| Net Cash Flow | $-387 | $-400 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -1,310 | -1,104 | N/A |
| Free Cash Flow | -1,310 | -1,104 | 0 |